Mississauga-based Ranbaxy Pharmaceuticals-Canada Inc. will be manufacturing and marketing Ran-Amlodipine tablets.
The Canadian subsidiary of India's largest pharmaceutical company, Ranbaxy Laboratories Limited, announced today it received final approval from Health Canada to make and market pills that help high blood pressure and chest pains caused by an insufficient supply of blood to the heart muscle.
Paul Drake, the president of Ranbaxy Pharmaceuticals-Canada Inc. on Matheson Blvd. E., says they're looking forward to marketing Ran-Amlodipine tablets as an antihypertensive-antianginal pill.
mississauganews.com
Pharmaceutical Process Equipment
